SELOKEN

This brand name is authorized in Austria, Brazil, Finland, France, Italy, Japan, Mexico.

Active ingredients

The drug SELOKEN contains one active pharmaceutical ingredient (API):

1	Metoprolol UNII TH25PD4CCB - METOPROLOL SUCCINATE
	Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation.
	Read more about Metoprolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AB02	Metoprolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	502303304152318, 502315030025103
FI	Lääkealan turvallisuus- ja kehittämiskeskus	422022
FR	Base de données publique des médicaments	68179830, 68679426
IT	Agenzia del Farmaco	023616028, 023616042
JP	医薬品医療機器総合機構	2149010F1025, 2149010G1047
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	172M91